Fingolimod in a patient with heart failure on the background of pulmonary arterial hypertension and coronary artery disease
Background: Fingolimod is the first oral immunomodulatory therapy approved for highly active relapsing remitting multiple sclerosis. Based on the distribution pattern of fingolimod interacting sphingosine-1-phosphat receptors in organism including immune system and cardiovascular system clinical mon...
Main Authors: | , , , |
---|---|
Other Authors: | |
Format: | Article |
Language: | English |
Published: |
Saechsische Landesbibliothek- Staats- und Universitaetsbibliothek Dresden
2015
|
Subjects: | |
Online Access: | http://nbn-resolving.de/urn:nbn:de:bsz:14-qucosa-167505 http://nbn-resolving.de/urn:nbn:de:bsz:14-qucosa-167505 http://www.qucosa.de/fileadmin/data/qucosa/documents/16750/1471-2377-14-126.pdf |